Precision in practice for Advanced/Recurrent Endometrial Cancer

by Stefan Ravello | Mar 20, 2025 | Hematology-Oncology, Oncology

Endometrial cancer is among the few cancers increasing in incidence and mortality in the United States. In its early stages, endometrial carcinoma has a five-year relative survival rate of 96%, but it decreases to 18% for those with metastases. Surprisingly, mortality...

The Promise of Prehabilitation Therapy in Lung Cancer

by mfenimore | Mar 13, 2025 | Oncology, Pulmonology

This curriculum equips healthcare professionals with the knowledge to implement neoadjuvant prehabilitation strategies—such as exercise, nutrition, stress reduction, and smoking cessation—to improve surgical outcomes and quality of life for lung cancer...

Unlocking the Potential: Advancements in ADC Therapy for Metastatic Triple Negative and HR+/HER2- Breast Cancer Treatment

by Stefan Ravello | Dec 9, 2024 | Oncology

This curriculum examines the latest advancements in antibody-drug conjugate (ADC) therapy for metastatic triple-negative breast cancer (mTNBC) and HER2-low (HR+/HER2-) breast cancer. It provides insights into mechanisms of action, emerging clinical data, and...

The Emerging Role of Biologics in COPD Management

by Stefan Ravello | Dec 9, 2024 | Pulmonology

Chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide, is a heterogeneous lung condition characterized by chronic respiratory symptoms caused by persistent airflow limitation due to airway and alveolar abnormalities. Initial COPD...

Bridging the Gap in Dialysis Care – Optimizing Hyperphosphatemia Management and Improving Patient Outcomes

by Stefan Ravello | Oct 28, 2024 | Nephrology, Nutrition, Pharmacy

Chronic kidney disease (CKD) is estimated to impact approximately 37 million individuals in the United States (U.S). Furthermore, about 786,000 persons are living with end-stage kidney disease (ESKD) and receive renal replacement therapy, either through maintenance...